Hcl Daisource

Lab Reagents

Diasource Laboratories manufactures the hcl daisource reagents distributed by Genprice. The Hcl Daisource reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Diasource. Other Hcl products are available in stock. Specificity: Hcl Category: Daisource

Test Assays information

Prazosin HCl
A5318-100 100 mg
EUR 199.2
Description: ?1 and ?2B-adrenoceptor antagonist. Also a potent antagonist at the melatonin MT3 receptor (Ki = 10.2 nM). Also available as part of the ?1-Adrenoceptor Tocriset? and Mixed Adre

Prazosin HCl
A5318-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: ?1 and ?2B-adrenoceptor antagonist. Also a potent antagonist at the melatonin MT3 receptor (Ki = 10.2 nM). Also available as part of the ?1-Adrenoceptor Tocriset? and Mixed Adre

Moxifloxacin HCl
A5323-200 200 mg
EUR 268.8
Description: Moxifloxacin HCl is anti-infective compound with a broad antibacterial spectrum.[1] Moxifloxacin is a fourth generation fluoroquinolone antibacterial agent with a broad antibacterial spectrum against Gram positive bacteria and Gram negative bacteria in vitro.

Moxifloxacin HCl
A5323-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Moxifloxacin HCl is anti-infective compound with a broad antibacterial spectrum.[1] Moxifloxacin is a fourth generation fluoroquinolone antibacterial agent with a broad antibacterial spectrum against Gram positive bacteria and Gram negative bacteria in vitro.

Moxifloxacin HCl
A5323-50 50 mg
EUR 129.6
Description: Moxifloxacin HCl is anti-infective compound with a broad antibacterial spectrum.[1] Moxifloxacin is a fourth generation fluoroquinolone antibacterial agent with a broad antibacterial spectrum against Gram positive bacteria and Gram negative bacteria in vitro.

Ziprasidone HCl
A5350-100 100 mg
EUR 199.2
Description: Atypical antipsychotic that displays combined serotonin and dopamine receptor antagonism. Displays high affinity at 5-HT2A receptors with a 5-HT2A/D2 affinity ratio greater than any other clinically available atypical antipsychotics (pKi values are 9.38,

Ziprasidone HCl
A5350-5.1 10 mM (in 1mL DMSO)
EUR 142.8
Description: Atypical antipsychotic that displays combined serotonin and dopamine receptor antagonism. Displays high affinity at 5-HT2A receptors with a 5-HT2A/D2 affinity ratio greater than any other clinically available atypical antipsychotics (pKi values are 9.38,

SRT1720 HCl
A4180-10 10 mg
EUR 309.6
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol.

SRT1720 HCl
A4180-200 200 mg
EUR 1730.4
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol.

SRT1720 HCl
A4180-5 5 mg
EUR 212.4
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol.

SRT1720 HCl
A4180-5.1 10 mM (in 1mL DMSO)
EUR 226.8
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol.

SRT1720 HCl
A4180-50 50 mg
EUR 825.6
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol.

SRT1720 HCl
A4180-S Evaluation Sample
EUR 97.2
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol.

Rosiglitazone HCl
A4310-100 100 mg
EUR 157.2
Description: Rosiglitazone is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.

Rosiglitazone HCl
A4310-200 200 mg
EUR 212.4
Description: Rosiglitazone is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.

Rosiglitazone HCl
A4310-25 25 mg
EUR 129.6
Description: Rosiglitazone is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.

Pioglitazone HCl
A4324-10 10 mg
EUR 142.8
Description: Pioglitazone HCl is a potent and highly selective agonist of PPAR? with IC50 value of 3?M[1].Pioglitazone HCl can increase both insulin-stimulated glucose uptake in peripheral tissues and insulin sensitivity in hepatic and adipose tissue.